Atomera Is Gaining Traction, But Still Remains Risky

Nov. 25, 2019 12:43 PM ETAtomera Incorporated (ATOM)6 Comments

Summary

  • The company is generating increasing interest from the industry trying out its MST technology.
  • But the pre-production agreements don't bring anywhere near sufficient amount of revenues for the company to be profitable or generate cash.
  • With cash sufficient for another 12 months or so, some clients will have to go into production with MST for Atomera to avoid having to go back to the markets.

We looked at Atomera (NASDAQ:ATOM) in June and noted that the company, which developed a technology called MST for speeding up transistors, achieved a technical break-through and was gaining traction with chip designers trying out its technology.

We briefly described the MST technology in our previous article, but a much more comprehensive take comes from SA contributor Vision and Value, which we highly recommend for those interested in how the MST technology works and how it fits in the semiconductor industry.

The company has really substantial IP. Over the last 12 months, it has grown its number of patents granted and pending from 184 to 230.

The earnings model is as follows. From the earnings deck:

Customers can be distinguished into five phases. From the Q3CC (our emphasis):

Phase 1 includes customers under NDA who are planning an evaluation of our technology. In phase 2 we deposit MST film on customers' wafers and conduct physical characterization. Phase 3 is where customers incorporate MST on their wafers during an R&D run in their fab and use the test results to justify licensing our technology. It is generally in Phase 3 that we are most likely to sign integration licenses with customers. Phase 4 where customers execute a manufacturing license and install MST on EPI tool in their fab and in Phase 5 customers get a distribution license and transition to production.

Below you can see how the number of customers in the different phases is growing (earnings deck):

With at least 50% of the top semiconductor companies somewhere in this graph as customers in different phases, one might wonder why the company is earning so little revenue still. From the earnings deck:

There are several categories of revenues:

  • Engineering services revenue from customers conducting MST deposition runs.
  • Upfront revenue for integration, manufacturing and distribution licenses.
  • Royalties based on the sale of licensed MST wafers and chips when they get into production.

Most of the customers are still in phase 1-3 where revenue streams aren't terribly significant. The money is in the licenses and royalties (phase 4 and 5) There are three different types of license grants:

  • Integration licenses, which give the customers the right to integrate MTS on their wafers, but this is done by Atomera. AKM (OTCPK:AHKSF) and STMicro (STM) already have integration licenses.
  • Manufacturing licenses grant customers the right to deposit MST on their wafers in their own fab, but the customers can only use those wafers for internal testing.
  • Distribution licenses allow customers to sell wavers to sell to third parties and Atomera also collects a royalty on these sales.

On October 30 of this year, the company announced a new licensee, which has the following characteristics (Q3CC):

The good news doesn't end there. Apparently this company is so large that while fabless it has allowed to have established its own proprietary manufacturing process with its foundry partners.

This opens the door directly to demonstrating Atomera's MST technology with this foundry partner. Surely, an interesting proposition. Here is management on the Q3CC:

You can imagine that if an important customer requests their foundry to implement MST we may immediately get a higher priority than if we are trying to convince that fab on our own... as the foundry gets to know us and the benefits of our technology, they would want to engage with us directly to make a technology that they would sell to the rest of the market.

There is also the fact that the company has two versions of its MST technology (earnings deck):

MST1 has the advantage that it is easier to integrate in manufacturing processes, but it can suffer from heat degradation. Luckily, the market seems to be evolving towards this (Q3CC, our emphasis):

Generally speaking, if a wafer can be manufactured using MST 1, we believe it will be easier to integrate and we'll give Atomera faster time to revenue. But MSC 1 will only be an option where the customers' process uses a lower DT regime. As a rule of thumb newer process now generally uses lower temperature profiles. So 28 nanometer is usually manufactured at lower temperatures then 65 nanometer.

Risks

This is about it for the good news. There are two main problems or risks for investors:

  • The economic potential isn't clear (at least not to us).
  • Revenues are still minimal and cash burn is going to increase.

What worries us quite a bit is that the company has already two (now three, but the third one was only acquired at the end of Q3 and isn't in the accounts) licensees, and these are significant names (STMicro and AKM), but that hasn't really moved any needle insofar as revenues are concerned.

Revenue really needs to increase by an order of magnitude, and we're supposing that this will happen when the clients move to acquire distribution licenses and Atomera will start to collect royalties.

That hasn't happened yet, and there are no ironclad guarantees that actually will happen, but the increasing interest in the technology is at least encouraging. Here is management (Q3CC):

The customers and programs we are working on today are each very high potential and capable of making the company successful on their own. When we get these folks into production we will certainly be a powerful IP provider to the semiconductor industry and a much more valuable member of the semiconductor ecosystem.

From the 10-Q:

The Company's operating plans for the next 12 months include increased research and development headcount and increased spending on outsourced fabrication and testing. Based on the funds it has available as of the date of the filing of this report, the Company believes that it has sufficient capital to fund its current business plans and obligations over, at least, 12 months from the date that these financial statements have been issued...

The company is going to lease an additional EPI tool to use for both customer wafers and internal R&D (Q3CC):

About a $75,000 a month increase with incremental R&D on tool and headcount.

Some data points:

  • The net loss in Q3 was $3.1M.
  • Cash consumption as well as non-GAAP operating expenses will be in the range of $11.5M to $12.5M for FY2019.
  • Q4 revenue will be in the range of $125K to $150K, which is half that of Q3. This is rather disappointing as the license revenue from the new licensee will be recognized in Q4, although supposedly some deferred revenue will show up on the balance sheet in Q4 as revenue is recognized when services are actually rendered according to ASC 606.
  • Cash at September 30, 2019, was $16.8M, down $2.3M from the end of Q2.

So it has cash for about another 12 months, and if there are no distribution licenses and royalties emerging in that time, it will have to go back to the market. The level of dilution has actually been fairly modest, given the lack of revenues:

ChartData by YCharts

Conclusion

Atomera is promising, as its technology is gaining interest by some of the biggest names in the industry. However, as long as these interested companies that are evaluating the MST technology are not including it in their production lines, the company isn't going to thrive, as revenues from pre-production agreements are simply too small for it to survive for long.

The most that can be said is that the increasing interest does increase the likelihood of customers incorporating the technology in their production lines, but there can be no guarantees here. So this is only for those intimately familiar with the technology who can handicap this with a greater degree of certainty, or investors that love high-risk, high-reward situations.

This article was written by

Shareholders Unite profile picture
18.51K Followers
Finding the next Roku while navigating the high-risk, high reward landscape

I'm a retired academic with three decades of experience in the financial markets.

Providing a marketplace service Shareholdersunite Portfolio

Finding the next Roku while navigating the high-risk, high reward landscape.

Looking to find small companies with multi-bagger potential whilst mitigating the risks through a portfolio approach.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (6)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.